COVID-19 will remain the third-largest killer for 2022, behind heart disease and cancer, even with the reduced numbers
THURSDAY, Dec. 15, 2022 (HealthDay News) — More than two years after the pandemic began, there is a bit of good news on death rates in the United States: They should be lower this year than during the past two years once final numbers are tallied. Still, they have not dropped to levels seen before COVID-19 swept across the country, preliminary data show.
Deaths are expected to remain about 13 percent higher than 2019 numbers for 2022. But they should be 7 percent lower than in 2021 and 3 percent lower than in 2020, based on an estimate of the first 11 months of 2022, the Associated Press reported. Though the death rate typically goes up annually as the population grows, so many people died during the first two years of the pandemic that it sped the pace. Unless there is a big surge this month, this could be the first annual decline since 2009, the AP reported.
COVID-19 will remain the third-largest killer for 2022, behind heart disease and cancer, even with the reduced numbers. The deadliest year in U.S. history was 2021, with 3.4 million deaths, the AP reported. Still, the U.S. COVID-19 vaccination program has prevented more than 3.2 million deaths since it began in late 2020, according to a modeling study released this week from the Commonwealth Fund.
COVID-19 has killed more than 1.1 million Americans, the AP reported, including 73,000 deaths alone in January, despite the overall lowered numbers this year. That was the third deadliest month since the beginning of the pandemic.
Heart disease deaths have also risen, though they, too, will be down from 2021, said Farida Ahmad, who leads mortality surveillance at the U.S. Centers for Disease Control and Prevention. Preliminary data did not reveal whether the number of cancer deaths would change. However, provisional drug overdose death rates for the first seven months of 2022 suggest those numbers stopped rising early this year.
Active Smoking Linked to Progression of Sickle Cell Retinopathy
Low Levels of Placental Growth Factor in Pregnancy Linked to Subsequent ADHD in Offspring
Air Pollution Does Not Impair Benefits of Walking in Reducing COPD Exacerbation Rate
Implant, Patient Survival Do Not Differ for Robotic and Conventional Total Joint Replacement
Physical Therapist-Supervised Exercise Improves Outcomes After ACL Reconstruction
Early Complications Common in Older Kidney Transplant Recipients
PET/MRI Offers Diagnostic, Prognostic Value in Pediatric Epilepsy
Less Intraoperative Crystalloid Fluid Not Tied to Worse Surgical Outcomes